Tag: Terumo

Treo

Treo abdominal stent graft system launches commercially in the USA

  Following approval this year by the US Food and Drug Administration (FDA) of the Treo abdominal aortic stent-graft system for the treatment of patients...

PRIZER, new multicentre PAD study, launches

A new post-market study investigating the effectiveness of the Renzan peripheral stent system (Terumo) in patients with peripheral arterial disease (PAD) has been...

Third-generation Anaconda endograft indicates “satisfactory” aneurysm exclusion at five years 

The third-generation Anaconda endograft (Terumo Aortic) provides “high technical success” and “satisfactory” five-year aneurysm exclusion and clinical success rates, a French multicentre prospective observational study (EPI-ANA-01) has found. The investigators note that longer-term...
Terumo Aortic's AAA stent grafts

Terumo acquires Aortica Corporation

Terumo Corporation today announced that it has decided to acquire Aortica Corporation, a US-based company dedicated to advancing the science of personalised vascular therapy.  Aortica...
virtue

Orchestra BioMed announce FDA breakthrough device designation for Virtue sirolimus-eluting balloon

Orchestra BioMed, in partnership with Terumo Corporation, today announced that the company has secured breakthrough device designation by the US Food and Drug Administration...

Virtue sirolimus-eluting balloon set for commercial release as Terumo and Orchestra...

Orchestra BioMed and Terumo have formed a global strategic partnership for the development and commercialisation of Virtue sirolimus-eluting balloon (SEB) in the percutaneous coronary...

Terumo gets CE mark for Kanshas drug-coated balloon catheter for lower...

Terumo has announced that it acquired CE mark for the Kanshas drug-coated balloon catheter used in the treatment of lower extremity peripheral arterial disease....

Vascutek and Bolton Medical merge as “Terumo Aortic”

Vascutek and Bolton Medical, subsidiaries of Terumo Corporation of Japan, have combined into Terumo Aortic. Combining the aortic companies into a single business, Terumo...

Terumo enters purchase agreement for XPro large bore vascular closure system

Terumo has entered into a definitive asset purchase agreement with Medeon Biodesign for its XPro large bore vascular closure system. The transaction consists of an...

£33m investment in Vascutek factory

Tokyo-based Terumo Corporation has announced an investment of £33 million in one of its subsidiary companies, Vascutek Limited, located near Glasgow, UK. According to a...
Bolton Medical Relay

First patient enrolled in Bolton Medical’s RelayPro FDA trial

The first patient has been enrolled in Bolton Medical’s RelayPro US Food and Drug Administration (FDA) Phase II clinical trial. This study will assess the...
Terumo

Terumo completes acquisition of vascular closure business and other assets of...

Terumo has announced that it has completed its acquisition of certain assets owned by Abbott and St Jude Medical. Terumo has acquired the Angio-Seal and...
Terumo

Terumo acquires Bolton to accelerate growth of its vascular graft business

Terumo Corporation has announced that it has entered into a definitive agreement under which it has agreed to acquire Bolton Medical from its parent...
Terumo

Terumo signs to acquire St Jude Medical and Abbott’s vascular closure...

Terumo has reached an agreement with Abbott and St Jude Medical to acquire certain products owned by both for a total of US$1.12 billion. Based...

St Jude Medical and Abbott to sell portion of vascular closure...

Abbott and St Jude Medical have announced an agreement in principle to sell certain products to Terumo Corporation. The transaction reflects a purchase price of...